Imperial College London

ProfessorSanjayPrasad

Faculty of MedicineNational Heart & Lung Institute

Professor of Cardiomyopathy
 
 
 
//

Contact

 

+44 (0)20 7352 8121s.prasad

 
 
//

Location

 

CMR UnitRoyal BromptonRoyal Brompton Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Vassiliou:2017:10.1371/journal.pone.0181077,
author = {Vassiliou, VS and Flynn, PD and Raphael, CE and Newsome, S and Khan, T and Ali, A and Halliday, BP and Studer, A and Malley, T and Sharma, P and Selvendran, S and Aggarwal, N and Sri, A and Berry, H and Donovan, J and Lam, W and Auger, D and Cook, SA and Pennell, DJ and Prasad, SK},
doi = {10.1371/journal.pone.0181077},
journal = {PLOS One},
title = {Lipoprotein(a) in patients with aortic stenosis: insights from cardiovascular magnetic resonance},
url = {http://dx.doi.org/10.1371/journal.pone.0181077},
volume = {12},
year = {2017}
}

RIS format (EndNote, RefMan)

TY  - JOUR
AB - BackgroundAortic stenosis is the most common age-related valvular pathology. Patients with aortic stenosis and myocardial fibrosis have worse outcome but the underlying mechanism is unclear. Lipoprotein(a) is associated with adverse cardiovascular risk and is elevated in patients with aortic stenosis. Although mechanistic pathways could link Lipoprotein(a) with myocardial fibrosis, whether the two are related has not been previously explored. In this study, we investigated whether elevated Lipoprotein(a) was associated with the presence of myocardial replacement fibrosis.MethodsA total of 110 patients with mild, moderate and severe aortic stenosis were assessed by late gadolinium enhancement (LGE) cardiovascular magnetic resonance to identify fibrosis. Mann Whitney U tests were used to assess for evidence of an association between Lp(a) and the presence or absence of myocardial fibrosis and aortic stenosis severity and compared to controls. Univariable and multivariable linear regression analysis were undertaken to identify possible predictors of Lp(a).ResultsThirty-six patients (32.7%) had no LGE enhancement, 38 (34.6%) had midwall enhancement suggestive of midwall fibrosis and 36 (32.7%) patients had subendocardial myocardial fibrosis, typical of infarction. The aortic stenosis patients had higher Lp(a) values than controls, however, there was no significant difference between the Lp(a) level in mild, moderate or severe aortic stenosis. No association was observed between midwall or infarction pattern fibrosis and Lipoprotein(a), in the mild/moderate stenosis (p = 0.91) or severe stenosis patients (p = 0.42).ConclusionThere is no evidence to suggest that higher Lipoprotein(a) leads to increased myocardial midwall or infarction pattern fibrosis in patients with aortic stenosis.
AU - Vassiliou,VS
AU - Flynn,PD
AU - Raphael,CE
AU - Newsome,S
AU - Khan,T
AU - Ali,A
AU - Halliday,BP
AU - Studer,A
AU - Malley,T
AU - Sharma,P
AU - Selvendran,S
AU - Aggarwal,N
AU - Sri,A
AU - Berry,H
AU - Donovan,J
AU - Lam,W
AU - Auger,D
AU - Cook,SA
AU - Pennell,DJ
AU - Prasad,SK
DO - 10.1371/journal.pone.0181077
PY - 2017///
SN - 1932-6203
TI - Lipoprotein(a) in patients with aortic stenosis: insights from cardiovascular magnetic resonance
T2 - PLOS One
UR - http://dx.doi.org/10.1371/journal.pone.0181077
UR - http://hdl.handle.net/10044/1/49955
VL - 12
ER -